Johnson and Johnson applies for emergency coronavirus vaccine use in Philippines
Manila: Drugmaker Johnson & Johnson has filed its application for emergency use authorisation of its COVID-19 vaccine in the Philippines, the country's Food and Drug Administration (FDA) chief said on Monday.
Read also: US puts JnJ in charge of plant that botched COVID vaccine, removes AstraZeneca
J&J's documents, which were submitted on Wednesday, are now under evaluation, FDA Director General Rolando Enrique Domingo told reporters. J&J, which has a single-shot coronavirus vaccine, is the seventh vaccine maker to seek approval in the Philippines.
Read also: Johnson and Johnson expands COVID-19 vaccine trial to include adolescents
Next Story
